RT @zev_dr: Please keep sharing https://t.co/ouWBFhw2rj
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please share
RT @zev_dr: Please keep sharing
RT @zev_dr: Please share https://t.co/ouWBFhNDiR
RT @zev_dr: Please keep sharing
RT @zev_dr: Please share https://t.co/ouWBFhNDiR
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @Juan_Jacko: No puedes dejar la Coca Cola pero si quieres que los demás dejen de respirar libremente. Aprende a comer y deja de fregar…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please keep sharing
RT @zev_dr: Please keep sharing
RT @zev_dr: Please keep sharing
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study - ScienceDirect https://t.co/s78250QR7m
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet
RT @zev_dr: please retweet
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
TO CIRCULATE ASAP PRIOR TO ANYTHING ELSE TRIED.-
RT @zev_dr: Please keep sharing https://t.co/ouWBFhw2rj
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @Alex49715131: A télécharger avant que ça ne disparaisse, oui,je sais,je suis un peu parano...
RT @zev_dr: Please keep sharing
RT @ScottAdamsSays: Small study, and retrospective (not the gold standard type), but add it to your data pile.
RT @irritatedwoman: I’m on this...and it works. https://t.co/D5xwMtWH5m
RT @zev_dr: Please keep sharing
RT @zev_dr: please retweet
Why isn’t this questioned? America has never denied early treatment before—making patients wait until they are critically ill and needing hospitalization/ICU! Tens of thousands of Drs have been successfully treating early since spring. PEER-REVIEWED STUDY:
RT @zev_dr: Please share https://t.co/ouWBFhNDiR
RT @zev_dr: Please share https://t.co/ouWBFhNDiR
RT @zev_dr: please retweet
RT @zev_dr: Please keep sharing https://t.co/ouWBFhw2rj
RT @zev_dr: Please keep sharing
RT @zev_dr: Please keep sharing
RT @zev_dr: please retweet
RT @ScottAdamsSays: Small study, and retrospective (not the gold standard type), but add it to your data pile.
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet
RT @BusyElves: Please RT. You know the #MSM won't. #Covid-19 early treatment. https://t.co/1nNCm8aUMj
RT @zev_dr: Please share
RT @zev_dr: Please share
RT @zev_dr: please retweet
RT @zev_dr: Please keep sharing
RT @tadei: @yammirya @Vale___Mx @bagameda @vissaeusmorenae nada hay comprobado? pues aqui hay algo que desmiente tu afirmación https://t.c…
RT @zev_dr: Please keep sharing
RT @zev_dr: Please share https://t.co/ouWBFhNDiR
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please keep sharing
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please keep sharing https://t.co/ouWBFhw2rj
RT @zev_dr: Please keep sharing
@JadePinkSameera @VPrasadMDMPH HCQ https://t.co/TN89qxME3I "Risk stratification-based treatment of COVID-19 outpatients as early as possible after symptom onset using triple therapy, including the combination of zinc with low-dose hydroxychloroquine, was a
RT @zev_dr: please retweet
RT @zev_dr: Please keep sharing
RT @zev_dr: Please keep sharing
RT @zev_dr: Please keep sharing
RT @zev_dr: Please keep sharing
RT @zev_dr: Please keep sharing
RT @zev_dr: Please keep sharing
RT @zev_dr: Please share
RT @Timothy_de_Illy: I believe I found the tweet. I took a screen shot. In the order presented, here are the 3 links: Study: https://t.c…
RT @zev_dr: Please keep sharing
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please keep sharing
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please keep sharing
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: please retweet
RT @zev_dr: Please share
RT @zev_dr: Please keep sharing
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please keep sharing
RT @zev_dr: please retweet
RT @zev_dr: Please share
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please keep sharing
⬇️⬇️⬇️
RT @zev_dr: Please share https://t.co/ouWBFhNDiR
RT @zev_dr: Please keep sharing https://t.co/ouWBFhw2rj
RT @zev_dr: please retweet
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please keep sharing
RT @marrmae1: @LATiffani1 .
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…
RT @zev_dr: Please keep sharing
RT @JoeRiley0311KAG: @PAHealthDept New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose…
RT @zev_dr: please retweet https://t.co/ouWBFhw2rj
RT @zev_dr: New peer reviewed published study-COVID-19 outpatients–early risk-stratified tx with zinc plus low dose hcq and azithromycin ht…